These findings revealed that rutin, tianshic acid, and quercetin-3β-D-glucoside could be forecasted as the active compounds of HQHG for ITP, while EGFR, CASP3, TNF, and STAT3 were the major targets for reaching this effect. The gene discussed is TNF; the disease is autoimmune thrombocytopenic purpura.